EIKON THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$5.31
-0.75%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 186 observations · as of Oct 30, 2026
1 month
-28.3%
3 months
-42.0%
6 months
-45.1%
1 year
-64.6%
Year to date
-64.6%
52-week range
$5.31 – $16.26
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$287.6M
P/E
-0.9
P/B
0.6
P/S
—
Revenue
—
Net income
—
Diluted EPS
—
Gross margin
—
Net margin
—
Return on equity
—
Total debt
$252.22M
Cash
$143.01M
Free cash flow
—
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$88.41M | — | — | -$65.21M |
| Mar 31, 2026 | $0 | -$82.96M | — | — | -$90.06M |
| Dec 31, 2025 | $0 | -$79.66M | — | — | -$41.79M |
| Sep 30, 2025 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent EIKN news
All market newsNo ticker-linked stories are in the current archive.